Legal Opinion
In Re Columbia University Patent Litigation
District Court, D. Massachusetts
Decided August 16, 2004No. MDL 1592PublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
WOLF, District Judge.
I. SUMMARY
On September 24, 2002, the United States Patent and Trademark Office (the “PTO”) issued U.S. Patent No. 6,455,275 (the “ ’275 patent”). The Trustees of Co lumbia University in the City of New York (“Columbia”) own the ’275 patent. The plaintiffs in these five cases are drug companies. They each license a portfolio of patent rights from Columbia, including the ’275 patent (the “Axel patents”). The plaintiffs contend that the ’275 patent is invalid and unenforceable and, therefore, refuse to pay Columbia royalties under their respective…
2Cases cited5 opinions
- Ethicon, Inc. v. Donald J. Quigg, Commissioner of Patents & Trademarks and the United States Patent & Trademark OfficeCourt of Appeals for the Federal Circuit · 1988
- Bloom Engineering Company, Inc. v. North American Manufacturing Company, Inc.Court of Appeals for the Federal Circuit · 1997
- In Re Stephen B. Bogese IICourt of Appeals for the Federal Circuit · 2002
- Symbol Technologies, Inc. v. Lemelson MedCourt of Appeals for the Federal Circuit · 2002
- Biogen Idec MA Inc. v. TRUSTEES OF COLUMBIA UNIVERSITY CITY OF NEW YORKDistrict Court, D. Massachusetts · 2004
3Cited by7 opinions
- In Re Columbia University Patent LitigationDistrict Court, D. Massachusetts · 2004
- Saint-Gobain Performance Plastics Corp. v. Advanced Flexible Composites, Inc.District Court, D. Massachusetts · 2006
- Cell Genesys, Inc. v. Applied Research Systems ARS Holding, N.V.District Court, D. Massachusetts · 2007
- Aplix IP Holdings Corp. v. Sony Computer Entertainment, Inc.District Court, D. Massachusetts · 2015
- Janssen Biotech, Inc. v. Celltrion Healthcare Co.District Court, D. Massachusetts · 2016
2 more not listed; retrieve them via the Exa API.